Antihypertensive Medicine Sales in Norway

The country ranked number 16 in 2022, Canada overtook $2.1 PPP Per Capita. Austria, Slovakia and Greece respectively ranked numbers 2, 3 and 4 in this ranking.

How does Norway rank in Antihypertensive Medicine Sales?

# 11 Countries US Dollars PPP Per Capita Last Year YoY 5-years CAGR
1 1 Austria 7.6 2023 +1.33% +2.55% View data
2 2 Germany 4.8 2023 -2.04% -1.59% View data
3 3 Greece 4.2 2023 0% +0.48% View data
4 4 Slovenia 4.2 2023 0% +6.96% View data
5 5 Latvia 2.8 2023 -9.68% -7.34% View data
6 6 Finland 2.2 2023 +4.76% +7.96% View data
7 7 Norway 2.1 2023 0% +0.98%
8 8 Estonia 1.8 2023 +5.88% +5.15% View data
9 9 Luxembourg 1.3 2023 0% +5.39% View data

Top Countries about Antihypertensive